Sitemap

  • Directives NCE
  • Directives Non Prescription
  • Directives - Pharmacovigilance
  • Directives - Laboratory & Quality Control
  • Directives - Vaccine Lot Release
  • Directives - Plasma Products Lot Release
  • Directives - Licensing
  • Training and Seminars
  • FAQ API
  • FAQ Generic
  • FAQ Biologics
  • FAQ NCE
  • FAQ Traditional
  • FAQ Health General
  • FAQ Combo Products
  • FAQ Bioequivalence(BE)
  • FAQ Clinical Trial
  • FAQ GMP
  • FAQ Laboratory & Quality Control
  • QUEST
  • Circular - Prescription
  • Circulars Biologics
  • Circulars NCE
  • Circulars Traditional
  • Circulars Health Supplements
  • Circulars - Non Prescription
  • Circulars - Veterinary
  • Circulars - Combo Products
  • Circulars - Cosmetics
  • Circulars - Clinical Trial
  • Circulars - Bioequivalence (BE)
  • Circulars - Active Pharmaceutical Ingredient (API)
  • Circulars - Pharmacovigilance
  • Circulars Plasma Products Lot Release
  • Circulars Vaccine Lot Release
  • Circulars Laboratory & Quality Control
  • Sebut Harga 2016
  • Publications
  • NPRA Publications
  • Announcement 2017
  • Announcement - Biologics
  • Announcement - NCE
  • Announcement - Traditional
  • Announcement - Health Supplements
  • Announcement - Veterinary
  • Announcement - Combo Products
  • Announcement - Bioequivalence(BE)
  • Recent Updates: BEEC
  • Announcement - Cosmetic
  • Announcement - Clinical Trial
  • Announcement - Pharmacovigilance
  • Announcement - GMP
  • Announcement - Laboratory & Quality Control
  • Safety Alerts 2022
  • Industries
  • Traditional
  • Guidelines Central
  • Guidelines - Non Prescription
  • Guidelines - Clinical Trial
  • Guidelines - Vaccine Lot Release
  • Guidelines - Plasma Products Lot Release
  • Guidelines - Licensing
  • Guidelines - FEO
  • Application Form
  • Application Form - Prescriptions
  • Application Form - Non Prescription
  • Application Form - Bioequivalence(BE)
  • Application Form - Cosmetic
  • Application Form - Pharmacovigilance
  • Application Form - Laboratory & Quality Control
  • Application Form - Active Pharmaceutical Ingredient (API)
  • Application Form - Vaccine Lot Release
  • Application Form - Plasma Products Lot Release
  • Application Form - Licensing
  • Application Form - FEO
  • none
  • test
  • Press Release

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti (Jalan Profesor Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Monday 24 January 2022, 10:19:17.
© Copyright 2022 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Search

Main Menu English

Choose Your Language